Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,483.0
10.7 (0.43%)

 

  • STI Straits Times Index
    2,483.0
    10.7 (0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,511.7
    2.5 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,476.0
    240.6 (1.04%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,217.5
    -1.9 (-0.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,511.6
    307.0 (1.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,906.5
    -39.2 (-0.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 764.8M
  • Value: 848.5M
  • Rise: 135
  • Fall: 143
  • Unch: 502

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.053+0.002
Vicplas Intl0.355-0.095
Sembcorp Marine0.143+0.001
OEL0.019+0.001
Singtel2.120-0.020
Synagie0.200-0.010
HPH Trust USD0.136+0.006
Oceanus^0.007-
QT Vascular0.007-
ThaiBev0.595+0.010

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BIOMARIN PHARMACEUTICAL BIOMARIN PHARMACEUTICAL
Updated on 25 Sep 2020 (End of trading day)
Last (USD): 77.390 Change: +0.810 High: 77.960 Remarks: -
Change (%): +1.06 Low: 75.835
Open 76.460 Yesterday's Close 76.58
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,770,362 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.13150 Trailing EPS (USD) e 0.67415 NAV (USD) b 17.8477
PE a - Trailing PE f 114.796 Price / NAV b 4.3361
Dividend (USD) d - Cash In Hand (USD) g 4.5156 Issued & Paid-up Shares c 181,350,000
Dividend Yield (%) d - Price / Cash In Hand g 17.138 Treasury Shares h -
Market Cap (M) 14,034.676 Enterprise Value (M) 14,155.822
Piotroski F Score 4 Exchange Code BMRN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 61.69 Free Float (%) 99.2
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 06 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BIOMARIN PHARMACEUTICAL NASDAQ 14,034.676 - 114.796 4.3361 -
Industry Biotechnology NASDAQ 2,704.137 678.317 6455.431 6.7641 0.656
Local Peer AMGEN INC NASDAQ 142,803.911 18.210 19.565 13.3975 2.402
Local Peer GILEAD SCIENCES INC NASDAQ 78,044.070 14.490 - 4.3293 4.088
Local Peer VERTEX PHARMACEUTICAL NASDAQ 69,852.040 59.357 33.570 9.2898 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,075.374 28.866 20.471 6.7431 -
Local Peer ILLUMINA INC NASDAQ 43,891.900 43.804 63.336 9.6191 -
Local Peer BIOGEN INC NASDAQ 43,263.777 7.347 7.300 3.8257 -
Local Peer SEATTLE GENETICS INC NASDAQ 32,180.745 - - 17.7395 -
Local Peer MODERNA INC NASDAQ 27,411.959 - - 9.3020 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 25,529.327 - - 10.0657 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,079.966 10.431 29.642 2.3907 -
Local Peer IMMUNOMEDICS INC NASDAQ 19,731.562 - - 33.2567 -
Local Peer INCYTE CORPORATION NASDAQ 18,928.398 42.354 - 8.0732 -
Other Local Peers ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), NOVAVAX INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), VAXCYTE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), UNIQURE N.V. (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), VIELA BIO INC (NASDAQ), CORTEXYME INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), COMPUGEN (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), EPIZYME INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), RETROPHIN INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ALECTOR INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), AKOUOS INC (NASDAQ), PERSONALIS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), VAXART INC (NASDAQ), NANTKWEST INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AGENUS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), IMMATICS N V (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OMEROS CORP (NASDAQ), PRECIGEN INC (NASDAQ), PASSAGE BIO INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), XBIOTECH INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), HUMANIGEN INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AVROBIO INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), ARDELYX INC (NASDAQ), IVERIC BIO INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), ATRECA INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AVID BIOSERVICES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), PROTHENA CORP PLC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KAMADA (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), IMV INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), METACRINE INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), AFFIMED N V (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CABALETTA BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), MEDICINOVA INC (NASDAQ), ADICET BIO INC (NASDAQ), VERASTEM INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), OTONOMY INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SESEN BIO INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), EQUILLIUM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), BELLUS HEALTH INC (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), INFLARX N V (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ORGENESIS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), EVOGENE LTD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ARAVIVE INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), BIOVIE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), COHBAR INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CURIS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), RECRO PHARMA INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), OCUGEN INC (NASDAQ), PRECIPIO INC (NASDAQ), ATYR PHARMA INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), VACCINEX INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), GEOVAX LABS INC (NASDAQ)
Global Peer AMGEN-T HKEx 1,083,533.900 17.635 19.045 13.1159 2.480
Global Peer CSL ASX 134,989.105 43.041 43.041 14.2384 0.989
Global Peer WUXI BIO HKEx 245,527.561 213.582 170.516 16.4365 -
Global Peer BEIGENE HKEx 197,084.394 - - 10.0259 -
Global Peer SINO BIOPHARM HKEx 161,549.456 52.635 58.741 4.6789 0.620
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,378.758 98.693 31.584 4.4868 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 23,018.897 - - 3.1484 -
Global Peer 3SBIO HKEx 21,365.820 19.351 14.230 1.8266 -
Global Peer VIVA BIOTECH HKEx 16,933.051 56.166 - 8.1397 0.184
Other Global Peers MESOBLAST LTD (ASX), HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), DPHARMA (Bursa), KINTOR PHARMA-B (HKEx), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), NANOVIRICIDES INC (NYSE American), IBIO INC (NYSE American), NEXT SCIENCE LTD (ASX), IMUGENE LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), ANTEOTECH LIMITED (ASX), IMMUTEP LTD (ASX), BIONOMICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), KAZIA THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), MEMPHASYS LTD (ASX), CT ENTERPRISE (HKEx), GENETIC TECHNOLOGIES (ASX), BIOTRON (ASX), ALTERITY THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), Suntar Eco-City (SGX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), REGENT PACIFIC (HKEx), RHINOMED LIMITED (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), ADALTA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), PATRYS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ANATARA LIFESCIENCES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), NANOLLOSE LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.110
+0.14 %
10 Days -+2.050
+2.72 %
20 Days --0.640
-0.82 %
Medium Term Return 3 Months --44.790
-36.66 %
6 Months --5.100
-6.18 %
1 Year -+9.990
+14.82 %
Long Term Return 2 Years --21.230
-21.53 %
3 Years --16.340
-17.43 %
5 Years --32.540
-29.60 %
Annualised Return Annualised --
-6.78 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 62.880 - 131.945 Change From 1 Year Low +14.510 % Change From 1 Year Low (%) +23.08
Change From 1 Year High -54.555 % Change From 1 Year High (%) -41.35
2 Years Range 62.880 - 131.945 Change From 2 Years Low +14.510 % Change From 2 Years Low (%) +23.08
Change From 2 Years High -54.555 % Change From 2 Years High (%) -41.35
5 Years Range 62.120 - 131.945 Change From 5 Years Low +15.270 % Change From 5 Years Low (%) +24.58
Change From 5 Years High -54.555 % Change From 5 Years High (%) -41.35
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 76.460 77.960 75.835 77.390 1,770,362 -
24 Sep 2020 77.400 78.000 75.020 76.580 2,584,213 -
23 Sep 2020 79.380 80.240 78.090 78.430 1,899,015 -
22 Sep 2020 77.390 80.940 75.410 79.360 2,708,707 -
21 Sep 2020 78.560 78.630 76.710 77.280 2,200,605 -
18 Sep 2020 78.810 79.720 77.180 79.380 4,440,634 -
17 Sep 2020 74.840 78.640 74.123 78.360 3,096,379 -
16 Sep 2020 75.500 76.390 75.090 75.640 1,689,533 -
15 Sep 2020 75.940 76.095 74.640 75.510 1,536,940 -
14 Sep 2020 72.990 76.140 72.990 75.340 2,450,320 -
11 Sep 2020 72.600 73.240 71.350 72.050 2,277,150 -
10 Sep 2020 74.110 75.150 71.500 71.870 3,263,115 -
09 Sep 2020 75.450 75.630 73.870 74.490 2,674,950 -
08 Sep 2020 74.720 75.720 73.700 74.490 1,634,766 -
04 Sep 2020 75.740 76.635 73.760 76.000 2,309,874 -
03 Sep 2020 77.743 77.825 75.390 75.840 2,579,621 -
02 Sep 2020 76.730 78.860 76.120 77.990 2,171,034 -
01 Sep 2020 77.850 78.040 75.560 76.000 2,313,876 -
31 Aug 2020 76.570 79.000 76.540 78.030 3,034,850 -
28 Aug 2020 75.990 76.440 74.796 76.380 1,789,574 -
27 Aug 2020 74.780 77.240 74.240 75.430 4,067,347 -
26 Aug 2020 73.860 75.320 73.701 74.890 2,551,029 -
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)
72.990 80.940 72.990 77.390 24,376,708 -
Previous 2 Weeks
(28 Aug 2020 to 11 Sep 2020)
75.990 80.940 72.990 72.050 24,048,810 -
4 Weeks from
(31 Jul 2020 to 27 Aug 2020)
121.810 121.925 72.990 75.430 73,797,654 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.